AV
AVTXF.US Avantium N.V
- Market cap
- USD 212M
- P/E
- -
- P/B
- 0.90x
- ROE
- -68.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is AVTXF.US undervalued?
Graham numberThe Graham number of Avantium N.V cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Avantium N.V fundamental analysis
No fundamental analysis for Avantium N.V yet.
Avantium N.V stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Avantium N.V
Avantium N.V., a chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands. It operates through Avantium R&D Solutions and Avantium Renewable Polymers. The company offers Releaf, boasts barrier properties for carbon dioxide and oxygen that leads to longer shelf life of packaged products used for packaging, textiles, film, and PEF applications. It also provides furandicarboxylic acid (FDCA), a building block for the high-perf…
Full company profileAvantium N.V financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Avantium N.V annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 10.5M | 12.7M | 11.3M | 13.8M | 9.86M | 10.9M | 17.8M | 19.7M | 21.0M | 14.6M | 18.6M |
| Gross Profit | 1.37M | -2.03M | -10.3M | -22.1M | -26.0M | -25.4M | -24.6M | -25.3M | -30.6M | 10.2M | -101M |
| Operating Income | -3.85M | -10.1M | -29.3M | -30.1M | -33.9M | -33.9M | -35.9M | -34.9M | -44.7M | -43.0M | -118M |
| EBITDA | -3.16M | -9.13M | -22.6M | -17.0M | -14.9M | -16.1M | -19.6M | -25.8M | -24.5M | -20.8M | -85.1M |
| Net Income | -14.1M | -16.8M | -68.4M | -23.5M | -22.8M | -24.4M | -28.1M | -31.4M | -26.9M | -22.5M | -87.9M |
| EPS | -0.41 | -0.54 | -2.00 | -0.69 | -0.66 | -0.62 | -0.60 | -0.73 | -0.36 | -1.70 | -3.49 |
| Balance Sheet | |||||||||||
| Total Assets | 86.2M | 169M | 114M | 96.5M | 70.0M | 77.7M | 164M | 228M | 289M | 356M | 332M |
| Total Liabilities | 39.0M | 10.5M | 22.8M | 28.3M | 23.7M | 27.6M | 70.6M | 175M | 191M | 207M | 211M |
| Shareholders' Equity | 47.1M | 158M | 91.2M | 68.2M | 46.2M | 50.0M | 82.6M | 46.2M | 95.9M | 153M | 129M |
| Cash & Short-term Investments | 14.2M | 100M | 83.3M | 45.4M | 26.6M | 34.9M | 64.9M | 35.2M | 23.9M | 55.8M | 23.8M |
| Total Debt | 26.4M | - | - | 10.8M | 9.71M | 10.7M | 38.7M | 109M | 149M | 155M | 171M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -2.99M | -5.87M | -8.85M | -23.1M | -13.4M | -12.6M | -11.2M | -18.8M | -45.1M | -27.7M | -97.2M |
| Capital Expenditure | 1.92M | 5.02M | 8.08M | 8.55M | 3.45M | 3.93M | 34.0M | 89.3M | 58.3M | 20.7M | 33.6M |
| Free Cash Flow | -4.91M | -10.9M | -16.9M | -31.6M | -16.9M | -16.5M | -45.1M | -108M | -103M | -48.4M | -131M |
| Ratios | |||||||||||
| ROE | -29.9% | -10.6% | -75.0% | -34.5% | -49.4% | -48.8% | -34.1% | -68.0% | -28.0% | -14.8% | -68.0% |
| ROA | -16.4% | -9.9% | -60.0% | -24.4% | -32.6% | -31.4% | -17.2% | -13.7% | -9.3% | -6.3% | -26.4% |
| Net Profit Margin | -134.5% | -132.5% | -606.0% | -170.3% | -231.5% | -223.7% | -157.8% | -159.4% | -127.7% | -154.3% | -471.6% |
| Debt to Equity | 0.56x | - | - | 0.16x | 0.21x | 0.21x | 0.47x | 2.36x | 1.56x | 1.01x | 1.33x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Avantium N.V dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | USD 103M | 3.35 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10 on May 20, 2025.
Who owns Avantium N.V
- Insiders 16.28%
- Institutions 2.94%
- Public & others 80.78%
- Shares outstanding 37.6M
- Free float 22.0M
Avantium N.V company profile
- Company name
- Avantium N.V
- Ticker
- AVTXF.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 245
- Fiscal year end
- December
- Address
- Zekeringstraat 29-31, Amsterdam, Netherlands, 1014 BV
- Phone
- 31 20 586 8080
- Website
- avantium.com
About Avantium N.V
Avantium N.V., a chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands. It operates through Avantium R&D Solutions and Avantium Renewable Polymers. The company offers Releaf, boasts barrier properties for carbon dioxide and oxygen that leads to longer shelf life of packaged products used for packaging, textiles, film, and PEF applications. It also provides furandicarboxylic acid (FDCA), a building block for the high-performance plant-based polymer polyethylene furanoate (PEF). In addition, the company offers YXY Technology which catalytically converts plant-based sugars into FDCA. Further, it is development and commercialization of the Dawn Technology, Parana Technology, and Volta Technology. The company was founded in 2000 and is headquartered in Amsterdam, the Netherlands.
Avantium N.V management
9- Mr. Tom B. van AkenCEO & Member of Management Board · born 1970
- Mr. Rogier Maurice Sven van WijkCFO & Member of the Management Board · born 1975
- Hero de JagerInterim Chief Operating Officer
- Mr. Gert-Jan M. GruterChief Technology Officer · born 1963
- Ms. Carmen PortocareroGeneral Counsel · born 1967
- Annelore Van ThielDirector of Human Resources
- Mr. Steven OlivierManaging Director of Avantium R&D Solutions · born 1964
- Ms. Chie Cheung YapManaging Director of Volta Technology · born 1974
- Mr. Marco JansenChief Commercial Officer · born 1970